Prognostic Significance of Visit-to-Visit Systolic Blood Pressure Variability: A Meta-Analysis of 77,299 Patients

Journal of Clinical Hypertension

Volumn 17, Issue 2, 2015, Pages 107-115

  Tai, Chenhui ^a   Sun, Yuxi ^a   Dai, Neng ^a   Xu, Dachun ^a   Chen, Wei ^a   Wang, Jiguang ^b   Protogerou, Athanase ^c   van Sloten, Thomas T ^d   Blacher, Jacques ^e   Safar, Michel E ^e   Zhang, Yi ^a   Xu, Yawei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA ARCH SYNDROME; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; VISIT TO VISIT SYSTOLIC BLOOD PRESSURE; ADULT; AGED; AMBULATORY CARE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; COMPLICATION; FEMALE; HYPERTENSION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTOLE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OFFICE VISITS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SYSTOLE;

EID: 84922863878     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12484     Document Type: Article

References (46)

1. WHO document. A global brief on hypertension. http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en. Accessed April 7, 2013.
2. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407-2415.
3. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension. 2005;46:156-161.
4. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539-546.
5. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357.
6. Hansen TW, Thijs L, Li Y, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55:1049-1057.
7. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938-948.
8. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
9. Schutte R, Thijs L, Liu YP, et al. Within-subject blood pressure level-not variability-predicts fatal and nonfatal outcomes in a general population. Hypertension. 2012;60:1138-1147.
10. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012;30:1241-1251.
11. Rothwell PM, HowardS C, Dolan E, et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469-480.
12. Muntner P, Levitan EB. Visit-to-visit variability of blood pressure: current knowledge and and future research directions. Blood Press Monit. 2013;18:232-238.
13. Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patient with type 2 diabetes: the ADVANCE trial. Circulation. 2013;128:1325-1334.
14. Mena L, Pintos S, Queipo NV, et al. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23:505-511.
15. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.
16. Duval S, Tweedie R. Trim and Fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463.
17. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta-Analysis Version 2. Englewood, NJ: Biostat; 2005.
18. Asayama K, Kikuya M, Schutte R, et al. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension. 2013;61:61-69.
19. Hashimoto T, Kikuya M, Ohkubo T, et al. Home blood pressure level, blood pressure variability, smoking, and stroke risk in Japanese men: the Ohasama Study. Am J Hypertens. 2012;25:883-891.
20. Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160-166.
21. Rossignol P, Cridlig J, Lehert P, et al. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Hypertension. 2012;60:339-346.
22. Hsieh YT, Tu ST, Cho TJ, et al. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5.5-year prospective analysis. Eur J Clin Invest. 2012;42:245-253.
23. Di Iorio B, Pota A, Sirico ML, et al. Blood pressure variability and outcomes in chronic kidney disease. Nephrol Dial Transplant. 2012;27:4404-4410.
24. Mallamaci F, Minutolo R, Leonardis D, et al. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int. 2013;84:381-389.
25. Suchy-Dicey AM, Wallace ER, Elkind MSV, et al. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the Cardiovascular Health Study. Am J Hypertens. 2013;26:1210-1217.
26. Chang TI, Flythe JE, Brunelli SM, et al. Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. J Hum Hypertens. 2014;28:18-24.
27. Di Iorio B, Di Micco L, Torraca S, et al. Variability of blood pressure in dialysis patients: a new marker of cardiovascular risk. J Nephrol. 2012;26:173-182.
28. Eguchi K, Hoshide S, Schwartz JE, et al. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens. 2012;25:962-968.
29. Poortvliet RK, Ford I, Lloyd SM, et al. Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2012;7:e52438.
30. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on atherosclerosis clinical perspective. Circulation. 2012;126:569-578.
31. Shimbo D, Newman JD, Aragaki AK, et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension. 2012;60:625-630.
32. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
33. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
34. Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335:432.
35. Mancia G. Short- and long-term blood pressure variability: present and future. Hypertension. 2012;60:512-517.
36. Mancia G, Parati G, Pomidossi G, et al. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension. 1986;8:147-153.
37. Conway J, Boon N, Davies C, et al. Neural and humoral mechanisms involved in blood pressure variability. J Hypertens. 1984;2:203-208.
38. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension. 1995;25:1276-1286.
39. Mancia G, Grassi G. Mechanisms and clinical implications of blood pressure variability. J Cardiovasc Pharmacol. 2000;35:S15-S19.
40. Muntner P, Joyce C, Levitan EB, et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011;29:2332-2338.
41. Nagai M, Hoshide S, Ishikawa J, et al. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens. 2011;5:184-192.
42. Krakoff LR. Fluctuation: does blood pressure variability matter? Circulation. 2012;126:525-527.
43. Brickman AM, Reitz C, Luchsinger JA, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010;67:564-569.
44. Hyre AD, Krousel-Wood MA, Muntner P, et al. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich). 2007;9:179-186.
45. Krousel-Wood MA, Muntner P, Islam T, et al. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009;93:753-769.
46. Levitan EB, Kaciroti N, Oparil S, et al. Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich). 2012;14:744-750.